Evidence map›Paper›PMID 34829982›Full record

ArticleInternational journal of molecular sciences2021

Effects of Metallic and Carbon-Based Nanomaterials on Human Pancreatic Cancer Cell Lines AsPC-1 and BxPC-3.

Barbara Wójcik, Ewa Sawosz, Jarosław Szczepaniak, Barbara Strojny, Malwina Sosnowska, Karolina Daniluk, Marlena Zielińska-Górska, Jaśmina Bałaban, André Chwalibog, Mateusz Wierzbicki

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Fullerenol CInternational journal of nanomedicine · 2024
    Article
  4. Influence of CCancers · 2023
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Barbara WójcikDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland.ORCID 0000-0002-0968-0204
Ewa SawoszDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland.ORCID 0000-0002-0016-4721
Jarosław SzczepaniakDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland.
Barbara StrojnyDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland.ORCID 0000-0002-2642-5491
Malwina SosnowskaDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland.
Karolina DanilukDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland.
Marlena Zielińska-GórskaDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland.ORCID 0000-0001-7714-6663
Jaśmina BałabanDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland.ORCID 0000-0001-8480-7327
André ChwalibogDepartment of Veterinary and Animal Sciences, University of Copenhagen, Groennegaardsvej 3, 1870 Frederiksberg, Denmark.ORCID 0000-0001-8150-2392
Mateusz WierzbickiDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland.ORCID 0000-0003-3623-8929
Warsaw University of Life Sciences · PLUniversity of Copenhagen · DK

Funding

National Science Center 2020/37/B/NZ7/03532
6 · The paper itself

Abstract

Pancreatic cancer, due to its asymptomatic development and drug-resistance, is difficult to cure. As many metallic and carbon-based nanomaterials have shown anticancer properties, we decided to investigate their potential use as anticancer agents against human pancreatic adenocarcinoma. The objective of the study was to evaluate the toxic properties of the following nanomaterials: silver (Ag), gold (Au), platinum (Pt), graphene oxide (GO), diamond (ND), and fullerenol (C

Indexed as

Antineoplastic AgentsApoptosisCell Line, TumorCell SurvivalDiamondFullerenesGene Expression Regulation, NeoplasticGoldGraphiteHumansNanostructuresNeoplasm ProteinsPancreatic NeoplasmsPlatinumSilverAntineoplastic AgentsDiamondFullerenesfullerenolGoldgraphene oxideGraphiteNeoplasm ProteinsPlatinumSilvercarbon-based nanomaterialscytotoxicityin vitrometallic nanoparticlespancreatic cancer

Identifiers

PMID34829982
PMCPMC8623931
OpenAlexW3213384709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.